MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Angiolipoma

(UMLS:C0206632)

Definition:: A benign neoplasm composed of a mixture of adipose tissue and blood vessels. (Dorland, 27th ed)
UMLS ID:: C0206632
MeSH ID:: D018206

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.450.550.100

Synonym(s)

Angiolipoma

ANGIOLIPOMA, BENIGN

Angiolipoma NOS

Angiolipoma, NOS

adipose tissue angiolipoma

angiolipoma

angiolipoma of fatty tissue

angiolipomas

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Tenofovir	FAERS: 2	US FAERS
2	Celecoxib	FAERS: 1	US FAERS
3	Valsartan	FAERS: 1	US FAERS
4	diclofenac hydroxyethylpyrrolidine	FAERS: 1	US FAERS
5	Alprazolam		OFFSIDES
6	Amantadine		OFFSIDES
7	Carbamazepine		OFFSIDES
8	Clonidine		OFFSIDES
9	Fluocinonide		OFFSIDES
10	Indinavir		OFFSIDES
11	Mupirocin		OFFSIDES
12	Nevirapine		OFFSIDES
13	Nizatidine		OFFSIDES
14	NuvaRing		OFFSIDES
15	Pamidronate		OFFSIDES
16	Pentoxifylline		OFFSIDES
17	Potassium		OFFSIDES
18	Potassium Iodide		OFFSIDES
19	Pravastatin		OFFSIDES
20	Pregabalin		OFFSIDES
21	Spironolactone		OFFSIDES
22	Valacyclovir		OFFSIDES
23	Zidovudine		OFFSIDES
24	efavirenz		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Lipoma	48.4%
2	Myelolipoma	48.4%
3	liposarcoma	47.3%
4	Angiomyolipoma	47.3%
5	Sarcoma	34.4%
6	Chondrosarcoma	30.1%
7	leiomyosarcoma	30.1%
8	synovial sarcoma	30.1%
9	Clear Cell Sarcoma of Soft Tissue	30.1%
10	Alveolar Soft Part Sarcoma	30.1%
11	Fibrosarcoma	26.2%
12	Osteosarcoma	26.2%
13	leukemia	25.4%
14	Neoplasms, Germ Cell and Embryonal	25.4%
15	Neoplasms, Glandular and Epithelial	25.4%
16	Germ Cell Cancer	25.4%
17	Carcinosarcoma	25%
18	Hemangiosarcoma	25%
19	lymphangiosarcoma	25%
20	Malignant Fibrous Histiocytoma	24.3%
21	Phyllodes Tumor	22.6%
22	Myoma	22.6%
23	Myxoma	22.6%
24	Neoplasms, Bone Tissue	22.6%
25	Neoplasms, Fibrous Tissue	22.6%
26	Smooth Muscle Tumor	22.6%
27	Desmoplastic Small Round Cell Tumor	22.6%
28	Chondroma	22.6%
29	Enchondroma	22.6%
30	Rhabdomyosarcoma	22.3%
31	Giant Cell Tumor of Bone	22.3%
32	Sarcoma, Myeloid	21.5%
33	Dermatofibrosarcoma	20.4%
34	Dermatofibrosarcoma Protuberans	20.4%
35	Neuroectodermal Tumors	19.8%
36	Alveolar rhabdomyosarcoma	18.5%
37	Carcinoma 256, Walker	17.7%
38	Neoplasms, Neuroepithelial	17.1%
39	Gliomatosis cerebri	17.1%
40	Histiocytic Disorders, Malignant	16.9%
41	fibroma	16.8%
42	Fibromatosis	16.8%
43	Osteoblastoma	16.8%
44	Osteoma	16.8%
45	Rhabdomyoma	16.8%
46	Chondromatosis	16.8%
47	Hamartoma	16.4%
48	Neoplasms, Hormone-Dependent	16.4%
49	Neoplasms, Multiple Primary	16.4%
50	Paraneoplastic Syndromes	16.4%
51	Precancerous Conditions	16.4%
52	Neoplasms, Second Primary	16.4%
53	Adenofibroma	15.7%
54	Fibroadenoma	15.7%
55	Sarcoma, Experimental	15.7%
56	Adenoma	14.8%
57	Ameloblastoma	14.8%
58	Angiokeratoma	14.8%
59	Carcinoma	14.8%
60	Chordoma	14.8%
61	Hemangioma	14.8%
62	hemangiopericytoma	14.8%
63	Lymphangioma	14.8%
64	Mesenchymoma	14.8%
65	Nevus	14.8%
66	Teratoma	14.8%
67	Hepatoblastoma	14.8%
68	Mixed Tumor, Mullerian	14.8%
69	Germinoma	14.8%
70	Teratocarcinoma	14.8%
71	Angiofibroma	14.8%
72	Epithelioma	14.8%
73	Sarcoma 180	14.6%
74	melanoma	14.5%
75	Fibromatosis, Aggressive	13.9%
76	Fibromatosis, Abdominal	13.9%
77	Basal cell carcinoma	12.9%
78	Carcinoma, Papillary	12.9%
79	Squamous cell carcinoma	12.9%
80	Craniopharyngioma	12.9%
81	Cystadenoma	12.9%
82	Mesothelioma	12.9%
83	Neuroectodermal Tumor, Melanotic	12.9%
84	Neuroendocrine Tumors	12.9%
85	Lymphangioleiomyomatosis	12.9%
86	Carcinoma, Basal Cell	12.9%
87	Meningioma	12.7%
88	Lymphoma	12.6%
89	Neurofibrosarcoma	12.6%
90	Endometrial Stromal Sarcoma	12.5%
91	Carcinoma, Ehrlich Tumor	12.2%
92	Dermoid Cyst	12.2%
93	Carcinoma, Lewis Lung	12.2%
94	Leukemia, Plasma Cell	12.2%
95	Adenoma, Acidophil	12%
96	Ganglioneuroma	12%
97	Glioma	12%
98	Malignant Glioma	12%
99	Trophoblastic Neoplasms	11.8%
100	Composite Lymphoma	11.8%
101	Leukemia, Experimental	11.7%
102	Mastocytosis	11.7%
103	Gastrointestinal Stromal Tumors	11.5%
104	Mastocytoma	11.4%
105	Cystadenocarcinoma	11.2%
106	Mucoepidermoid Carcinoma	11.2%
107	Mastocytosis, Systemic	11.2%
108	Medulloblastoma	10.9%
109	Cyst	10.8%
110	Neoplastic Processes	10.8%
111	Neoplastic Syndromes, Hereditary	10.8%
112	Pregnancy Complications, Neoplastic	10.8%
113	Carcinoid Tumor	10.8%
114	Neurilemmoma	10.8%
115	Hutchinson's Melanotic Freckle	10.8%
116	Melanoma, Amelanotic	10.8%
117	Neoplasms, Experimental	10.6%
118	Melanoma, Experimental	10%
119	Plasmacytoma	9.9%
120	Malignant histiocytosis	9.8%
121	Leukemia L1210	9.8%
122	Leukemia P388	9.8%
123	Histiocytic sarcoma	9.8%
124	Acanthoma	9.8%
125	Adenocarcinoma	9.7%
126	Carcinoma in Situ	9.7%
127	Carcinoma, Transitional Cell	9.7%
128	Dysgerminoma	9.7%
129	Hemangioendothelioma	9.7%
130	Neuroma	9.7%
131	Papilloma	9.7%
132	Pseudomyxoma Peritonei	9.7%
133	Seminoma	9.7%
134	Papillomatosis	9.7%
135	Adenomatosis, Pulmonary	9.7%
136	Adenomatous Polyps	9.7%
137	Carcinoma, Large Cell	9.7%
138	Carcinoma, Small Cell	9.7%
139	Bowen's Disease	9.6%
140	Paraganglioma	9.6%
141	Astrocytoma	9.5%
142	Ependymoma	9.5%
143	oligodendroglioma	9.5%
144	Ganglioglioma	9.5%
145	gliosarcoma	9.5%
146	Anaplastic astrocytoma	9.5%
147	Anaplastic Oligodendroglioma	9.5%
148	Leukemia, Radiation-Induced	9.5%
149	Thymoma	9%
150	Malignant Carcinoid Syndrome	8.9%
151	Choriocarcinoma	8.7%
152	Carcinoma, Lobular	8.7%
153	Abdominal Neoplasms	8.5%
154	Erythroplasia	8.5%
155	Follicular cyst	8.5%
156	Head and Neck Neoplasms	8.5%
157	Mucocele	8.5%
158	Pilonidal Cyst	8.5%
159	Soft Tissue Neoplasms	8.5%
160	Thoracic Neoplasms	8.5%
161	Thyroglossal Cyst	8.5%
162	Synovial Cyst	8.5%
163	Aberrant Crypt Foci	8.5%
164	Glioblastoma	8.3%
165	Neuroblastoma	8.3%
166	Glioblastoma Multiforme	8.3%
167	Pheochromocytoma	7.9%
168	Neoplasms, Radiation-Induced	7.9%
169	Ganglioneuroblastoma	7.7%
170	Multiple Endocrine Neoplasia	7.4%
171	Hodgkin Disease	7.3%
172	Lymphoma, Non-Hodgkin	7.3%
173	Dupuytren Contracture	7.2%
174	Adenoid Cystic Carcinoma	7.2%
175	Adenocarcinoma, Clear Cell	7.2%
176	Cholangiocarcinoma	7.2%
177	Cervical Intraepithelial Neoplasia	7.2%
178	Hemangioblastoma	7.2%
179	Lymphoma, Extranodal NK-T-Cell	7.2%
180	Urticaria Pigmentosa	7.1%
181	Retinoblastoma	7%
182	Paraneoplastic Encephalomyelitis	6.8%
183	Mammary Neoplasms, Experimental	6.7%
184	Carcinoid Heart Disease	6.5%
185	Leukemia, Myelomonocytic, Chronic	6.5%
186	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	6.5%
187	Lymphomatoid Granulomatosis	6.2%
188	Digestive System Neoplasms	6%
189	Endocrine Gland Neoplasms	6%
190	Eye Neoplasms	6%
191	Nervous System Neoplasms	6%
192	Klatskin Tumor	6%
193	Primary amyloidosis	5.9%
194	Bone neoplasms	5.7%
195	Leukoplakia	5.7%
196	Lymphocele	5.7%
197	Pancreatic Cyst	5.7%
198	Skin Neoplasms	5.7%
199	Hematologic Neoplasms	5.7%
200	Nephroblastoma	5.6%
201	Barrett Esophagus	5.6%
202	Breast Cyst	5.6%
203	Actinic keratosis	5.6%
204	Mediastinal Cyst	5.6%
205	Neoplasm Invasiveness	5.6%
206	Neoplasm Metastasis	5.6%
207	Neoplasm Recurrence, Local	5.6%
208	Parovarian Cyst	5.6%
209	Pericardial Cyst	5.6%
210	Splenic Neoplasms	5.6%
211	Thymic Cyst	5.6%
212	Carcinogenesis	5.6%
213	Myxoid cyst	5.6%
214	Metastasis	5.6%
215	Hepatocellular Adenoma	5.2%
216	Hydatidiform Mole	5.2%
217	Tuberous Sclerosis	5.1%
218	Basal Cell Nevus Syndrome	5.1%
219	Sturge-Weber Syndrome	5%
220	Carcinoma, Pancreatic Ductal	5%
221	Retroperitoneal Neoplasms	4.9%
222	Hemangioma, Cavernous	4.9%
223	Leukemia, T-Cell	4.8%
224	Leukemia, B-Cell	4.8%
225	Mesoblastic Nephroma	4.8%
226	neurofibroma	4.8%
227	Lymphoma, Follicular	4.8%
228	T-Cell Lymphoma	4.8%
229	Mantle cell lymphoma	4.8%
230	Acoustic Neuroma	4.8%
231	Leukemia, Myeloid, Chronic-Phase	4.8%
232	Multiple Endocrine Neoplasia Type 1	4.4%
233	Prolactinoma	4.3%
234	Growth Hormone-Secreting Pituitary Adenoma	4.3%
235	Optic Nerve Glioma	4.3%
236	Waldenstrom Macroglobulinemia	4.2%
237	Multiple Myeloma	4.2%
238	Vipoma	4.2%
239	Corpus Luteum Cyst	4.1%
240	Ovarian Cysts	4.1%
241	Parathyroid Neoplasms	4.1%
242	Peritoneal Neoplasms	4.1%
243	Thyroid Neoplasm	4.1%
244	Thyroid carcinoma	4.1%
245	Liver Neoplasms, Experimental	3.9%
246	granulosa cell tumor	3.7%
247	Carcinoma, Ovarian Epithelial	3.7%
248	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
249	Leukemia, Large Granular Lymphocytic	3.6%
250	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3.6%
251	Lymphoma, T-Cell, Cutaneous	3.6%
252	Lymphoma, AIDS-Related	3.6%
253	Enteropathy-Associated T-Cell Lymphoma	3.6%
254	Primary Effusion Lymphoma	3.6%
255	Adenomatous Polyposis Coli	3.5%
256	insulinoma	3.4%
257	Pancreatic Neoplasm	3.4%
258	Choledochal Cyst	3.4%
259	Tracheal Neoplasms	3.4%
260	Mouth Neoplasms	3.4%
261	Central Nervous System Neoplasms	3.4%
262	Vascular Neoplasms	3.4%
263	Thymus Neoplasms	3.4%
264	Genital Neoplasms, Female	3.3%
265	Pancreatic Pseudocyst	3.3%
266	Peutz-Jeghers Syndrome	3.3%
267	Leukoplakia, Oral	3.3%
268	Paraneoplastic Cerebellar Degeneration	3.3%
269	Lymphatic Metastasis	3.3%
270	Neoplasms, Unknown Primary	3.3%
271	Leukemic Infiltration	3.3%
272	Breast Neoplasms, Male	3.3%
273	Neoplasm Micrometastasis	3.3%
274	Triple Negative Breast Neoplasms	3.3%
275	Adrenocortical carcinoma	3.2%
276	Gastrinoma	3.1%
277	Glucagonoma	3.1%
278	Mycosis Fungoides	3%
279	Lymphomatoid Papulosis	3%
280	Plasmablastic lymphoma	3%
281	Nasopharyngeal carcinoma	2.9%
282	Leydig Cell Tumor	2.9%
283	Esophageal Neoplasms	2.7%
284	Renal Cell Carcinoma	2.7%
285	Papillary Renal Cell Carcinoma	2.7%
286	Limbic Encephalitis	2.7%
287	Thyroid Nodule	2.6%
288	Carcinoma, Endometrioid	2.6%
289	Adrenal Gland Neoplasms	2.6%
290	Gastrointestinal Neoplasms	2.6%
291	Genital Neoplasms, Male	2.6%
292	Liver neoplasms	2.6%
293	Uveal Neoplasms	2.6%
294	Denys-Drash Syndrome	2.5%
295	Urologic Neoplasms	2.5%
296	Sebaceous Gland Neoplasms	2.5%
297	Spinal Neoplasms	2.5%
298	Bone Marrow Neoplasms	2.5%
299	Polycystic Ovary Syndrome	2.4%
300	Burkitt Lymphoma	2.4%
301	Lambert-Eaton Myasthenic Syndrome	2.4%
302	Testicular Neoplasms	2.4%
303	Meningeal Neoplasms	2.2%
304	Opsoclonus-Myoclonus Syndrome	2.1%
305	Sezary Syndrome	2%
306	Xeroderma Pigmentosum	1.9%
307	Myelitis, Transverse	1.8%
308	Ear Neoplasms	1.7%
309	Eyelid Neoplasms	1.7%
310	Lung Neoplasms	1.7%
311	Nose Neoplasms	1.7%
312	Pleural Neoplasms	1.7%
313	ovarian neoplasm	1.7%
314	Cell Transformation, Viral	1.6%
315	Brain Neoplasms	1.6%
316	Salivary Gland Neoplasms	1.6%
317	Spinal Cord Neoplasms	1.6%
318	Tongue Neoplasms	1.6%
319	Palatal Neoplasms	1.6%
320	Uterine Neoplasms	1.6%
321	Vaginal Neoplasms	1.6%
322	Vulvar Neoplasms	1.6%
323	Uterine Cancer	1.6%
324	Fallopian Tube Neoplasms	1.6%
325	Meningeal Carcinomatosis	1.6%
326	Pituitary Adenoma	1.5%
327	Pituitary Neoplasms	1.5%
328	Pharyngeal Neoplasms	1.4%
329	Central Nervous System Cysts	1.3%
330	Bile Duct Neoplasms	1.3%
331	gallbladder neoplasm	1.3%
332	Intestinal Neoplasms	1.3%
333	Penile Neoplasms	1.3%
334	Prostatic Neoplasms	1.3%
335	Stomach Neoplasms	1.3%
336	Polycythemia Vera	1.3%
337	Bronchial Neoplasms	1.2%
338	Zollinger-Ellison syndrome	1.2%
339	Multiple Pulmonary Nodules	1.2%
340	Supratentorial Neoplasms	1.2%
341	Endometrial Neoplasms	1.2%
342	Laryngeal neoplasm	1.1%
343	Bladder Neoplasm	1.1%
344	Kidney Neoplasm	1.1%
345	Ureteral Neoplasms	1.1%
346	Urethral Neoplasms	1.1%
347	Brain Stem Neoplasms	1%
348	Hypopharyngeal Neoplasms	1%
349	Pleural Effusion, Malignant	1%
350	Hypopharyngeal Cancer	1%
351	Parotid Neoplasms	1%
352	Prostatic Neoplasms, Castration-Resistant	1%
353	Nelson Syndrome	1%
354	Choroid Plexus Papilloma	0.9%
355	Cecal Neoplasms	0.8%
356	Duodenal Neoplasms	0.8%
357	Tonsillar Neoplasms	0.8%
358	Cerebellar Neoplasms	0.8%
359	Nasopharyngeal Neoplasms	0.7%
360	Colorectal Neoplasms	0.7%
361	Radicular Cyst	0.7%
362	Appendiceal Neoplasms	0.7%
363	Colonic Neoplasms	0.7%
364	Rectal Neoplasms	0.7%
365	Paranasal Sinus Neoplasms	0.6%
366	Anus Neoplasms	0.5%
367	Sigmoid Neoplasms	0.5%
368	Maxillary Sinus Neoplasms	0.5%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262